These effects were mediated through BDNF-TrkB and mTOR signaling, key mechanisms known to control dendritic complexity and soma size [30, 47, 48], of which the functional status is impaired in mood disorders [33, 49] and Parkinson's disease [50]. This evidence concerns the gene NTRK2 and Parkinson disease.